drugset / Trial / NCT06601127
Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to evaluate efficacy and safety of tiprogrel in the treatment of patients with acute ischemic cerebrovascular events.
Timeline
- Start
- 2025-02-21
- Primary completion
- 2026-04-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | — | — |
| Subject | Tiprogrel | Unknown | — | — |
| Background | Aspirin | Small molecule | — | — |